BrainParrot

India Takes a Historic Leap Towards Self-Reliance: Union Minister Shri Shivraj Singh Chouhan Dedicates Country’s First Indigenous H5N1 Bird Flu Vaccine to the Nation in Bhopal

GS3Full notePublished: · Updated:

Source: PIB (Press Information Bureau) · Read the original ↗

Summary

Union Agriculture Minister Shivraj Singh Chouhan dedicated India's first indigenous chicken vaccine against H5N1 avian influenza to the nation in Bhopal. The vaccine comes from ICAR-NIHSAD, Bhopal. It is priced at ₹1–2 per dose so that small poultry farmers can afford it, and the Minister called it the world's first vaccine against this particular variant. He also announced a new ₹300 crore state-of-the-art laboratory for Bhopal.

UPSC relevance: GS3 — S&T (biotech/veterinary), Agriculture & animal husbandry; GS2 — Health/One Health

Key facts for Prelims

  • The vaccine is India's first indigenous chicken vaccine against Avian Influenza (H5N1), developed by ICAR-NIHSAD, Bhopal. The institute is in Madhya Pradesh and is a BSL-3 high-containment facility under ICAR.
  • NADCP: launched at Mathura in 2019 against FMD and Brucellosis; 100% centrally funded.
  • NIHSAD's earlier indigenous vaccines (per the article): Gumboro disease, Brucella abortus S-19 Delta, Classical Swine Fever and African Swine Fever.
  • 'Lumpi-ProVacInd' is the indigenous Lumpy Skin Disease vaccine, developed by scientists at Hisar and Izatnagar.
  • The diseases named for livestock economic loss are FMD, Lumpy Skin Disease (LSD), Brucellosis and Peste des Petits Ruminants (PPR). PPR affects sheep and goats.
  • First H5N1 outbreak in India: 2006, Navapur, Maharashtra.
  • H5N1 can transmit to mammals and humans (zoonosis).

Data and details

  • Vaccine price is ₹1–2 per dose. It is described as the world's first vaccine against this variant of bird flu.
  • New lab at Bhopal: ₹300 crore (estimated).
  • Animal husbandry contributes 14% of India's GDP; the poultry sector accounts for another 1%. Livestock are described as 'moving ATMs' that give farmers regular monthly income.
  • Average annual losses (Minister's figures): FMD ₹22,000 crore; LSD ₹20,000 crore; Brucellosis ₹9,212 crore; PPR ₹4,683 crore. Together about ₹56,000 crore.
  • 2006 Navapur outbreak: 10 lakh chickens died, and lakhs more were culled and buried. About 9 lakh chickens died in 2021 and 2 lakh "this year" (2026).
  • More than 500 bird flu outbreaks since 2006.
  • 147 crore 16 lakh free FMD vaccine doses administered under the National Animal Disease Control Program. Brucellosis is said to be under control.
  • LSD outbreak, 2022: 32.8 lakh animals infected and 1.86 lakh deaths.
  • Two indigenous COVID-19 vaccines were developed in nine months through a PM-led task force, cited as precedent.
  • Research team: Dr S. Nagarajan, Dr Manoj Kumar, Dr C. Tosh, Dr H. V. Murugkar, Dr Aniket Sanyal, Dr Senthil Kumar D., Dr Naveen Kumar and Dr Yogisharadhya R. Dr Aniket Sanyal is the NIHSAD Director; ICAR DG Dr M. L. Jat was present.
  • Biosafety conditions on researchers: sanitisation before and after leaving the lab, 120 litres of water daily for bathing, and no pets at home during the research. They also worked through weekends for months.
  • The launch was held in Bhopal rather than Delhi, to credit the scientists at the place of development.
  • The Minister also criticised opposition leaders for questioning constitutional institutions and Indian capabilities while abroad. This is political rhetoric with no policy content.

Static–dynamic linkage

The static concept is that animal disease control is both an economic and a public-health problem. Highly pathogenic avian influenza (HPAI) destroys poultry flocks and farm incomes. It can also cross over to mammals and humans, so animal-health science links to pandemic preparedness (the "One Health" approach). Indigenous vaccine capacity matters for three reasons. It cuts import dependence. It lets the strain in the vaccine be matched to the virus circulating in India. It also keeps the cost low enough for small farmers. This ties into the Aatmanirbhar Bharat idea in S&T.

Syllabus mapping: GS3 – S&T: Indigenisation of technology, biotechnology applications | GS3 – Agriculture: animal husbandry economics, livestock disease control | GS2 – Health: zoonoses and One Health

Background primer

ICAR-National Institute of High Security Animal Diseases (NIHSAD), Bhopal

What it is:
A premier ICAR institute for research on exotic and emerging animal pathogens. It is India's Biosafety Level-3 (BSL-3) high-containment facility.
Founded:
Established in 1984 as the High Security Animal Disease Laboratory (HSADL) and later renamed.
Members:
It functions under the Indian Council of Agricultural Research (ICAR), Ministry of Agriculture & Farmers' Welfare. (Governance is through ICAR; a separate member structure is not confirmed from a trusted source.)
Mandate:
Research on exotic and emerging animal pathogens, disease diagnosis, and bio-containment of high-risk organisms. It is a reference lab for avian influenza, Newcastle disease and other transboundary and zoonotic diseases under the One Health framework.
Why it matters:
The high-containment design allows safe work on dangerous pathogens such as HPAI. The article's references to scientists sanitising on entry and exit and to strict biosafety protocols reflect this.

National Animal Disease Control Programme (NADCP)

What it is:
A programme launched by PM Modi at Mathura on 11 Sept 2019 to control and eradicate Foot & Mouth Disease (FMD) and Brucellosis.
Mandate:
100% FMD vaccination of livestock twice a year, and a one-time brucellosis vaccination of female bovine calves aged 4–8 months.

Additional context

  • The vaccine is an inactivated H5N1 (Clade 2.3.2.1a) HPAI vaccine for chickens developed by ICAR-NIHSAD. PIB notes that more than 500 combined outbreaks of H5N1 and H5N8 subtypes have been reported since the first detection in 2006.
  • GKToday reports that this clade is responsible for most bird flu outbreaks in India and that no specific commercial vaccine for it was previously available.
  • Policy angle: GKToday states that India follows a "detect and cull" policy for HPAI in domestic poultry and does not permit preventive H5N1 vaccination. Whether this policy has been revised for the new vaccine is not confirmed from a trusted source. For comparison, a DAHD policy has allowed vaccination against the low-pathogenic H9N2 strain, with the vaccine strain supplied by ICAR-NIHSAD.
  • Latest NADCP data from PIB: 147.16 crore FMD doses administered. Reported FMD outbreaks fell from 132 in 2019 to 40 by 2025, and brucellosis outbreaks from 22 in 2019 to 15 in 2025.
  • NIHSAD's international standing: It is among six global facilities designated to securely hold rinderpest virus material (Category A Rinderpest Holding Facility, WOAH–FAO).

Mains dimensions

  • Economic stakes: The ₹56,000 crore combined annual loss from FMD, LSD, Brucellosis and PPR, plus the 14% (animal husbandry) and 1% (poultry) GDP shares, show why disease control protects rural incomes. Cheap vaccines (₹1–2/dose) widen access for small farmers.
  • Recurring outbreaks: Over 500 outbreaks since 2006 are evidence of an endemic problem. Mortality and culling losses repeated in 2021 and 2026 (10 lakh in 2006; about 9 lakh in 2021; 2 lakh this year).
  • Self-reliance in S&T: Precedents cited are the COVID vaccines, the LSD vaccine (Lumpi-ProVacInd) and NIHSAD's earlier vaccines. The BSL-3 lab environment is a prerequisite for such work, and the ₹300 crore lab adds capacity.
  • One Health and zoonotic risk: Avian influenza can spill over to mammals and humans, so poultry vaccination is a public-health measure as well as an agricultural one.
  • Policy question (analytical): Moving from a cull-based approach to vaccination has trade and surveillance implications. Vaccinated flocks can complicate outbreak detection and export certification. A clear regulatory pathway is needed. Treat this as a consideration for answers, not a reported fact.
  • Institutional capability: Scientists' dedication and biosafety discipline show the human side of high-containment research.

Possible Mains question

**GS3, 15 marks:** "Indigenous development of veterinary vaccines can safeguard livelihoods and strengthen public health preparedness. Discuss with reference to recent developments against bird flu and other livestock diseases in India."

Related topics

  • National Animal Disease Control Programme and Livestock Health & Disease Control Programme
  • One Health approach / National One Health Mission; zoonotic diseases
  • Biosafety levels (BSL-1 to BSL-4) and biosecurity
  • Role of ICAR and the Department of Animal Husbandry & Dairying
  • Rinderpest eradication and WOAH

Topics: GS3

How we write and check these notes →

All current affairs of 20 November 2026 → · UPSC Current Affairs